Cargando…

Financial and feasibility implications of the treatment of hepatitis C virus in Italy: scenarios and perspectives

BACKGROUND: Hepatitis C virus (HCV) affects an estimated number of people between 130 million and 210 million worldwide. In the next few years, the Italian National Health Service will face a growing trend of patients requiring HCV antiviral treatments. The aim of the analysis was to estimate the ti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Croce, Davide, Bonfanti, Marzia, Restelli, Umberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982504/ https://www.ncbi.nlm.nih.gov/pubmed/27540306 http://dx.doi.org/10.2147/CEOR.S106769

Ejemplares similares

Organisational and financial consequences of the early discharge of patients treated for acute bacterial skin and skin structure infection and osteomyelitis in infectious disease departments in Greece, Italy and Spain: a scenario analysis
por: Restelli, Umberto, et al.
Publicado: (2019)

Co-Design as Enabling Factor for Patient-Centred Healthcare: A Bibliometric Literature Review
por: Silvola, Sofia, et al.
Publicado: (2023)

New Highly Active Antiretroviral drugs and generic drugs for the treatment of HIV infection: a budget impact analysis on the Italian National Health Service (Lombardy Region, Northern Italy)
por: Restelli, Umberto, et al.
Publicado: (2015)

Cost of human immunodeficiency virus infection in Italy, 2007–2009: effective and expensive, are the new drugs worthwhile?
por: Rizzardini, Giuliano, et al.
Publicado: (2012)

Cost-effectiveness analysis of dolutegravir plus backbone compared with raltegravir plus backbone, darunavir+ritonavir plus backbone and efavirenz/tenofovir/emtricitabine in treatment naïve and experienced HIV-positive patients
por: Restelli, Umberto, et al.
Publicado: (2017)

Cost-Utility Analysis of Lopinavir/Ritonavir versus Atazanavir + Ritonavir Administered as First-Line Therapy for the Treatment of HIV Infection in Italy: From Randomised Trial to Real World
por: Foglia, Emanuela, et al.
Publicado: (2013)

Correction: Cost-Utility Analysis of Lopinavir/Ritonavir versus Atazanavir + Ritonavir Administered as First-Line Therapy for the Treatment of HIV Infection in Italy: From Randomised Trial to Real World
por: Foglia, Emanuela, et al.
Publicado: (2014)

Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service
por: Restelli, Umberto, et al.
Publicado: (2014)

Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy
por: Restelli, Umberto, et al.
Publicado: (2019)

Intraprocedural contrast-enhanced ultrasound (CEUS) in liver percutaneous radiofrequency ablation: clinical impact and health technology assessment
por: Mauri, Giovanni, et al.
Publicado: (2014)

Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial
por: Restelli, Umberto, et al.
Publicado: (2017)

Update of the budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial
por: Restelli, Umberto, et al.
Publicado: (2017)

Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study
por: Restelli, Umberto, et al.
Publicado: (2017)

Cost-utility and budget impact analyses of the use of NEPA for chemotherapy-induced nausea and vomiting prophylaxis in Italy
por: Restelli, Umberto, et al.
Publicado: (2017)

Monocentric Analysis of the Effectiveness and Financial Consequences of the Use of Lenograstim versus Filgrastim for Mobilization of Peripheral Blood Progenitor Cells in Patients with Lymphoma and Myeloma Receiving Chemotherapy and Autologous Stem Cell Transplantation
por: Restelli, Umberto, et al.
Publicado: (2020)

Cost of Relapse Management in Patients with Schizophrenia in Italy and Spain: Comparison Between Lurasidone and Quetiapine XR
por: Restelli, Umberto, et al.
Publicado: (2020)

Hepatitis C Virus Infection Trends in Italy
por: Lavanchy, Daniel
Publicado: (2012)

Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in Italy
por: Cuypers, Lize, et al.
Publicado: (2017)

The Evolving Incidence of Hepatitis C Virus Infection in Italy
por: Pellicano, Rinaldo, et al.
Publicado: (2012)

Elimination of Hepatitis Viruses: Bangladesh Scenario
por: Al Mahtab, Mamun
Publicado: (2017)

Cost-Effectiveness of Testing and Treatment for Hepatitis B Virus and Hepatitis C Virus Infections: An Analysis by Scenarios, Regions, and Income
por: Tordrup, David, et al.
Publicado: (2020)

Clinical and Financial Implications of 2 Treatment Strategies for Donor-derived Hepatitis C Infections
por: Stewart, Zoe A., et al.
Publicado: (2021)

Protocol Implementation for Normothermia in Surgery Settings in Italy: Budget-Impact Analysis
por: Monzani, Roberta, et al.
Publicado: (2020)

Hepatitis C Virus infections trends in Italy, 1996-2006
por: Torre, Giuseppe La, et al.
Publicado: (2011)

Analysis of the correlation between mortality in nursing homes and among elderly population in Italy during the first phase of COVID-19 pandemic
por: SEBASTIANO, ANTONIO, et al.
Publicado: (2022)

Assessment of the Costs Related to West Nile Virus Monitoring in Lombardy Region (Italy) between 2014 and 2018
por: Defilippo, Francesco, et al.
Publicado: (2022)

Eleven-Year Distribution Pattern of Hepatitis C Virus in Southern Italy
por: Marascio, Nadia, et al.
Publicado: (2012)

Optimization of hepatitis C virus screening strategies by birth cohort in Italy
por: Kondili, Loreta A., et al.
Publicado: (2020)

Cost analysis of dalbavancin versus standard of care for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) in two Italian hospitals
por: Bai, Francesca, et al.
Publicado: (2023)

Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district
por: Polilli, Ennio, et al.
Publicado: (2016)

Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impact
por: Zignego, Anna Linda, et al.
Publicado: (2012)

Phylogeny and phylodinamic of Hepatitis C in Italy
por: Ciccozzi, Massimo, et al.
Publicado: (2012)

Patient’s preferences for health scenarios associated with hepatitis C and its treatment
por: Tinè, Fabio
Publicado: (2009)

Hepatitis C Virus; Its Implication for Endodontists
por: Mahboobi, Nima, et al.
Publicado: (2014)

Organizational Impact of the Introduction of a New Portable Syringe Pump for Iloprost Therapy in Italian Hospital Settings
por: Restelli, Umberto, et al.
Publicado: (2015)

Financial scenarios for a reinforced site maintenance and consolidation programme
Publicado: (2019)

Financial scenarios for a reinforced site maintenance and consolidation programme
Publicado: (2019)

Assessment of the Financial Capacity in Elderly: Approach and Challenges in Indian Scenario
por: Chithra, Nellai K., et al.
Publicado: (2021)

The Complex Epidemiological Scenario of West Nile Virusin Italy
por: Barzon, Luisa, et al.
Publicado: (2013)

A Synopsis of Hepatitis C Virus Treatments and Future Perspectives
por: Medina, Christian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d5329e3651031c2kh799kim0i5